Accessibility Menu
Sysmex logo

Sysmex(OTC) SSMXY

Current Price$9.29
Market Cap$5.77BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+64%
5 Year-76%
1 Year-46%
1 Month+11%
Sysmex last closing stock price
MetricPriceDate
Last closeUSD 9.292026-07-24
Sysmex stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.01%USD 9.992026-07-17
1 month+10.99%USD 8.372026-06-24
3 month+6.66%USD 8.712026-04-24
Year to date-4.72%USD 9.752025-12-31
1 year-45.58%USD 17.072025-07-24
3 year-57.44%USD 21.832023-07-25
5 year-75.59%USD 38.062021-07-23
Since inception+63.94%USD 5.672011-10-17

Sysmex Financials at a Glance

Market Cap

$5.77BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥507.09B

Net Income (TTM)

¥35.97B

EPS (TTM)

$0.38

P/E Ratio

24.52

Dividend

$0.24

Beta (Volatility)

0.72 (Low)

Price

$9.29

Volume

27,115

Open

$9.34

Previous Close

$9.29

Daily Range

$9.29 - $9.35

52-Week Range

$8.01 - $17.19

Estimated Earnings Date

Aug 5, 2026

SSMXY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sysmex

Sysmex Corporation, headquartered in Kobe, Japan, is a leading developer, manufacturer, and distributor of diagnostic instruments, reagents, and specialized software. The company serves a wide range of medical needs, focusing on hematology, urinalysis, immunochemistry, and oncology diagnostics.

Products and Services
  • Diagnostic instruments for hematology and urinalysis
  • Automated systems for immunochemistry assays
  • Flow cytometers for critical condition diagnostics
Growth Outlook
  • Strategic alliance with QIAGEN for cancer diagnostics development
  • Expansion into digital medicine with IT solutions for diagnostics
  • Global reach, exporting products to approximately 190 countries
Financial Highlights
  • Recent quarterly revenue of 141.39 billion JPY, showing strong demand
  • Net income of 1.76 billion JPY in the latest quarter, reflecting profitability
  • TTM gross profit margin of 51.14%, indicating operational efficiency
Sysmex Corporation has established itself as a key player in the medical instruments and supplies industry. The company's diverse product offerings cater to various diagnostic needs, making it a vital partner for healthcare institutions worldwide. The strategic alliance with QIAGEN N.V. enhances Sysmex's capabilities in cancer diagnostics, positioning the company for future growth. With a strong focus on digital medicine, Sysmex is adapting to the evolving healthcare landscape, ensuring its relevance in the market. Recent financial performance highlights a robust revenue stream and profitability, underscoring the company's operational efficiency and market demand. Overall, Sysmex Corporation presents a compelling opportunity for investors interested in the healthcare sector.
AI Generated • Jul 23, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10,861

CEO

Hisashi Ietsugu

Website

www.sysmex.co.jp/corporate/info/group.html

Headquarters

Kobe, HY 651-0073, JP

SSMXY Financials

Key Financial Metrics (TTM)

Gross Margin

51.14%

Operating Margin

12.43%

Net Income Margin

7.09%

Return on Equity

7.27%

Return on Capital

11.40%

Return on Assets

5.01%

Earnings Yield

4.08%

Dividend Yield

2.57%

Payout Ratio

63.29%

Stock Overview

Market Cap

$5.77BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

621.49M

Volume

27.11K

Avg. Volume

177.95K

Financials (TTM)

Gross Profit

¥259.29B

Operating Income

¥63.97B

EBITDA

¥112.75B

Operating Cash Flow

¥74.87B

Capital Expenditure

-¥33.37B

Free Cash Flow

¥41.50B

Cash & ST Invst.

¥84.48B

Total Debt

¥70.79B

Sysmex Performance Analysis

Sysmex annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 3,030,365,730-6.4%
20242024-03-31JPY 3,195,755,5625.5%
20252025-03-31JPY 3,336,449,8284.4%
20262026-03-31JPY 3,318,064,119-0.6%
Sysmex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-25.4%
Q22025-09-3022.0%
Q32025-12-311.5%
Q42026-03-318.0%
Sysmex annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 0.54-13.8%
20242024-03-31JPY 0.552.0%
20252025-03-31JPY 0.562.9%
20262026-03-31JPY 0.38-33.1%
Sysmex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-58.8%
Q22025-09-30228.8%
Q32025-12-31-2.0%
Q42026-03-31-87.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

¥141.39B

-0.3%

Gross Profit

¥69.30B

-5.3%

Gross Margin

49.01%

N/A

Market Cap

$5.77BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$531.59K

N/A

Employees

10,861

N/A

Net Income

¥1.76B

-84.1%

EBITDA

¥27.30B

-19.2%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

¥84.48B

-6.4%

Total Debt

¥70.79B

+9.3%

Accounts Receivable

¥178.31B

+9.4%

Inventory

¥96.03B

+17.4%

Long Term Debt

¥61.19B

+10.3%

Short Term Debt

¥9.60B

+3.7%

Return on Assets

5.01%

N/A

Return on Invested Capital

10.57%

N/A

Free Cash Flow

¥13.12B

-26.3%

Operating Cash Flow

¥23.87B

-18.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CNVVYConvaTec Group Plc
$11.70+3.80%
TRSBF3SBio Inc.
$2.15+0.00%
SKHCFSonic Healthcare Limited
$13.80+0.00%
FLMNFFielmann AG
$50.75+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
SOFISoFi Technologies
$16.46-0.01%
TAT&T
$24.13+0.05%

Questions About SSMXY

What is the current price of Sysmex?

Sysmex is trading at $9.29 per share.

What is the 52-week range for Sysmex?

Over the past 52 weeks, Sysmex has traded between $8.01 and $17.19.

How much debt does Sysmex have?

As of the most recent reporting period, Sysmex reported total debt of ¥443.03M.

How much cash does Sysmex have on hand?

Sysmex reported ¥528.74M in cash and cash equivalents in its most recent financial results.

What is Sysmex’s dividend yield?

Sysmex currently has a dividend yield of 2.57%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services